O	0	7	Sharing
O	8	10	in
O	11	15	care
O	15	16	:
O	17	25	engaging
O	26	30	care
O	31	39	partners
O	40	42	in
O	43	46	the
O	47	51	care
O	52	55	and
O	56	69	communication
O	70	72	of
O	73	79	breast
O	80	86	cancer
O	87	95	patients
O	95	96	.

O	97	103	Family
O	104	106	is
O	107	112	often
O	113	123	overlooked
O	124	126	in
O	127	133	cancer
O	134	138	care
O	138	139	.

O	140	142	We
O	143	152	developed
O	153	154	a
B-intervention	155	162	patient
I-intervention	162	163	-
I-intervention	163	169	family
I-intervention	170	176	agenda
I-intervention	177	184	setting
O	185	197	intervention
O	198	200	to
O	201	207	engage
O	208	214	family
O	215	217	in
O	218	224	cancer
O	225	229	care
O	230	243	communication
O	243	244	.

O	245	247	We
O	248	257	conducted
O	258	259	a
O	260	265	pilot
O	266	276	randomized
O	277	287	controlled
O	288	293	trial
O	294	295	(
O	295	306	NCT03283553
O	306	307	)
O	308	310	of
O	311	319	patients
O	320	322	on
O	323	329	active
O	330	339	treatment
O	340	343	for
O	344	350	breast
O	351	357	cancer
O	358	361	and
O	362	367	their
O	368	374	family
O	375	376	"
O	376	380	care
O	381	388	partner
O	388	389	.
O	389	390	"
O	391	403	Intervention
O	404	409	dyads
O	410	411	(
O	411	412	n
O	413	414	=
B-intervention-participants	415	417	69
O	417	418	)
O	419	428	completed
O	429	430	a
O	431	435	self
O	435	436	-
O	436	448	administered
O	449	458	checklist
O	459	461	to
O	462	469	clarify
O	470	474	care
O	475	482	partner
O	483	488	roles
O	488	489	,
O	490	499	establish
O	500	501	a
O	502	508	shared
O	509	514	visit
O	515	521	agenda
O	521	522	,
O	523	526	and
O	527	537	facilitate
O	538	545	MyChart
O	546	553	patient
O	554	560	portal
O	561	567	access
O	567	568	.

O	569	576	Control
O	577	582	dyads
O	583	584	(
O	584	585	n
O	586	587	=
B-control-participants	588	590	63
O	590	591	)
O	592	600	received
B-control	601	606	usual
I-control	607	611	care
O	611	612	.

O	613	615	We
O	616	624	assessed
O	625	637	intervention
O	638	651	acceptability
O	652	655	and
O	656	663	initial
O	664	671	effects
O	672	676	from
O	677	681	post
O	681	682	-
O	682	687	visit
O	688	695	surveys
O	696	699	and
O	700	707	MyChart
O	708	719	utilization
O	720	722	at
O	723	724	6
O	725	730	weeks
O	730	731	.

O	732	734	At
O	735	743	baseline
O	743	744	,
O	745	749	most
O	750	758	patients
O	759	760	(
O	760	762	89
O	762	763	.
O	763	764	4
O	764	765	%
O	765	766	)
O	767	770	but
O	771	774	few
O	775	779	care
O	780	788	partners
O	789	790	(
O	790	791	1
O	791	792	.
O	792	793	5
O	793	794	%
O	794	795	)
O	796	800	were
O	801	811	registered
O	812	815	for
O	816	823	MyChart
O	823	824	.

O	825	829	Most
O	830	838	patients
O	839	840	(
O	840	842	79
O	842	843	.
O	843	844	4
O	844	845	%
O	845	846	)
B-outcome	847	853	wanted
I-outcome	854	859	their
I-outcome	860	864	care
I-outcome	865	872	partner
I-outcome	873	875	to
I-outcome	876	880	have
I-outcome	881	887	access
I-outcome	888	890	to
I-outcome	891	896	their
I-outcome	897	904	records
O	905	908	and
O	909	911	39
O	911	912	.
O	912	913	4
O	913	914	%
O	915	917	of
O	918	922	care
O	923	931	partners
B-outcome	932	940	reported
I-outcome	941	950	accessing
I-outcome	951	958	MyChart
O	958	959	.

O	960	962	In
O	963	973	completing
O	974	977	the
O	978	987	checklist
O	987	988	,
O	989	997	patients
O	998	1001	and
O	1002	1006	care
O	1007	1015	partners
O	1016	1024	endorsed
O	1025	1031	active
O	1032	1045	communication
O	1046	1051	roles
O	1052	1055	for
O	1056	1059	the
O	1060	1064	care
O	1065	1072	partner
O	1073	1076	and
O	1077	1087	identified
O	1088	1089	a
O	1090	1097	similar
O	1098	1103	visit
O	1104	1110	agenda
O	1110	1111	:
O	1112	1116	most
O	1117	1118	(
O	1118	1119	>
O	1120	1122	90
O	1122	1123	%
O	1123	1124	)
B-outcome	1125	1133	reported
I-outcome	1134	1137	the
I-outcome	1138	1147	checklist
I-outcome	1148	1151	was
I-outcome	1152	1156	easy
I-outcome	1156	1157	,
I-outcome	1158	1164	useful
I-outcome	1164	1165	,
I-outcome	1166	1169	and
I-outcome	1170	1181	recommended
I-outcome	1182	1184	it
I-outcome	1185	1187	to
I-outcome	1188	1194	others
O	1194	1195	.

B-outcome	1196	1198	At
I-outcome	1199	1200	6
I-outcome	1201	1206	weeks
O	1206	1207	,
O	1208	1220	intervention
O	1221	1222	(
O	1222	1224	vs
O	1225	1232	control
O	1232	1233	)
O	1234	1238	care
O	1239	1247	partners
O	1248	1252	were
B-outcome	1253	1257	more
I-outcome	1258	1264	likely
I-outcome	1265	1267	to
I-outcome	1268	1270	be
I-outcome	1271	1281	registered
I-outcome	1282	1285	for
I-outcome	1286	1293	MyChart
O	1294	1295	(
B-iv-bin-percent	1295	1297	75
I-iv-bin-percent	1297	1298	.
I-iv-bin-percent	1298	1299	4
I-iv-bin-percent	1299	1300	%
O	1301	1303	vs
B-cv-bin-percent	1304	1305	1
I-cv-bin-percent	1305	1306	.
I-cv-bin-percent	1306	1307	6
I-cv-bin-percent	1307	1308	%
O	1308	1309	;
O	1310	1311	p
O	1312	1313	<
O	1314	1315	0
O	1315	1316	.
O	1316	1319	001
O	1319	1320	)
O	1320	1321	,
B-outcome	1322	1324	to
I-outcome	1325	1329	have
I-outcome	1330	1336	logged
I-outcome	1337	1339	in
O	1340	1341	(
B-iv-bin-percent	1341	1343	43
I-iv-bin-percent	1343	1344	.
I-iv-bin-percent	1344	1345	5
I-iv-bin-percent	1345	1346	%
O	1347	1349	vs
B-cv-bin-percent	1350	1351	0
I-cv-bin-percent	1351	1352	%
O	1352	1353	;
O	1354	1355	p
O	1356	1357	<
O	1358	1359	0
O	1359	1360	.
O	1360	1363	001
O	1363	1364	)
O	1365	1368	and
B-outcome	1369	1375	viewed
I-outcome	1376	1384	clinical
I-outcome	1385	1390	notes
O	1391	1392	(
B-iv-bin-percent	1392	1394	30
I-iv-bin-percent	1394	1395	.
I-iv-bin-percent	1395	1396	4
I-iv-bin-percent	1396	1397	%
O	1398	1400	vs
B-cv-bin-percent	1401	1402	0
I-cv-bin-percent	1402	1403	%
O	1403	1404	;
O	1405	1406	p
O	1407	1408	<
O	1409	1410	0
O	1410	1411	.
O	1411	1414	001
O	1414	1415	)
O	1415	1416	,
O	1417	1420	but
O	1421	1425	were
O	1426	1428	no
B-outcome	1429	1433	more
I-outcome	1434	1440	likely
I-outcome	1441	1443	to
I-outcome	1444	1452	exchange
I-outcome	1453	1459	direct
I-outcome	1460	1468	messages
I-outcome	1469	1473	with
I-outcome	1474	1484	clinicians
O	1485	1486	(
B-iv-bin-percent	1486	1487	1
I-iv-bin-percent	1487	1488	.
I-iv-bin-percent	1488	1489	5
I-iv-bin-percent	1489	1490	%
O	1491	1493	vs
B-cv-bin-percent	1494	1495	0
I-cv-bin-percent	1495	1496	%
O	1496	1497	;
O	1498	1499	p
O	1500	1501	=
O	1502	1503	0
O	1503	1504	.
O	1504	1507	175
O	1507	1508	)
O	1508	1509	.

O	1510	1512	No
O	1513	1524	differences
O	1525	1527	in
B-outcome	1528	1536	patients
I-outcome	1536	1537	'
I-outcome	1538	1545	MyChart
I-outcome	1546	1549	use
O	1550	1554	were
O	1555	1563	observed
O	1563	1564	,
O	1565	1568	but
O	1569	1581	intervention
O	1582	1590	patients
O	1591	1595	more
B-outcome	1596	1601	often
I-outcome	1602	1608	viewed
I-outcome	1609	1617	clinical
I-outcome	1618	1623	notes
O	1624	1625	(
B-iv-bin-percent	1625	1627	50
I-iv-bin-percent	1627	1628	.
I-iv-bin-percent	1628	1629	7
I-iv-bin-percent	1629	1630	%
O	1631	1633	vs
B-cv-bin-percent	1634	1635	9
I-cv-bin-percent	1635	1636	.
I-cv-bin-percent	1636	1637	5
I-cv-bin-percent	1637	1638	%
O	1638	1639	;
O	1640	1641	p
O	1642	1643	<
O	1644	1645	0
O	1645	1646	.
O	1646	1649	001
O	1649	1650	)
O	1650	1651	.

O	1652	1653	A
O	1654	1661	patient
O	1661	1662	-
O	1662	1668	family
O	1669	1675	agenda
O	1676	1683	setting
O	1684	1696	intervention
O	1697	1700	was
O	1701	1711	acceptable
O	1712	1715	and
O	1716	1724	affected
O	1725	1731	online
O	1732	1741	practices
O	1742	1744	of
O	1745	1751	cancer
O	1752	1760	patients
O	1761	1764	and
O	1765	1769	care
O	1770	1778	partners
O	1778	1779	.
